跳至主要内容
临床试验/ACTRN12612000221853
ACTRN12612000221853已完成未知

ROLLIS: Radioguided Occult Lesion Localisation using Iodine Seeds to localise impalpable breast lesions: The Pilot Extension Study

Royal Perth Hospital0 个研究点目标入组 120 人开始时间: 2012年2月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
Female

入选标准

  • 1. Women aged over 40 years
  • 2. Non-palpable breast tumour
  • 4. Participant eligible for breast conserving surgery (BCS)
  • based on clinical and radiologic evaluation
  • 6. Benign impalpable lesions, where participant requests
  • lesion be removed
  • 7. Intraductal lesions (papillomas)
  • 8. Lesions that are histologically indeterminate” on core
  • biopsy ( histology shows concerning features and removal
  • of further tissue for assessment to exclude cancer)
  • 9. Insertion of up to two seeds per participant (either
  • to bracket” larger or elongated lesions or for multiple
  • lesions (two in one breast or one in each breast)
  • 10.Periareolar lesions (providing the participant does not
  • require scintigraphy for sentinel node biopsy)

排除标准

  • 1. Male patient
  • 2. Female, age less than 40 years
  • 3. Pregnancy or lactation
  • 4. Periareolar lesion (where sentinel lymph node localization is
  • 5. Contraindication to breast conserving surgery
  • 6. Recent Nuclear Medicine or PET radioisotope administration that may adversely affect the procedure (isotopes with long half life eg gallium 67, thallium )

研究者

相似试验